Acquisition of FlexBiosys, Inc - Additional Information (Detail) - USD ($) $ in Thousands		6 Months Ended
	Apr. 17, 2023	Jun. 30, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Goodwill		$ 870,688	$ 855,513
FlexBiosys, Inc.
Business Acquisition [Line Items]
Business combination date of acquistion	Apr. 17, 2023
Equity consideration	$ 41,100
Cash consideration	29,000
Business Combination, Indemnification Assets, Range of Outcomes, Value, High	$ 6,300
Shares of common stock issued for acquisition	31,415	31,415
Value of common stock issued	$ 41,100
Business combination contingent consideration	6,600	$ 42,000
Net liabilities assumed	14,100
Business combination, intangible assets	12,600
Intangible Asset Residual Value	14,400
Transaction costs		400
Goodwill		$ 14,355
FlexBiosys, Inc. | Common Stock
Business Acquisition [Line Items]
Equity consideration	5,400
Value of common stock issued	$ 5,400